<VariationArchive VariationID="1694468" VariationName="NM_001849.4(COL6A2):c.101_104del (p.Asn34fs)" VariationType="Deletion" Accession="VCV001694468" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-07-09" MostRecentSubmission="2022-07-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1686902" VariationID="1694468">
      <GeneList>
        <Gene Symbol="COL6A2" FullName="collagen type VI alpha 2 chain" GeneID="1292" HGNC_ID="HGNC:2212" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46098112" stop="46132848" display_start="46098112" display_stop="46132848" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47518032" stop="47552762" display_start="47518032" display_stop="47552762" Strand="+" />
          </Location>
          <OMIM>120240</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001849.4(COL6A2):c.101_104del (p.Asn34fs)</Name>
      <CanonicalSPDI>NC_000021.9:46111574:AAACAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46111575" stop="46111578" display_start="46111575" display_stop="46111578" variantLength="4" positionVCF="46111574" referenceAlleleVCF="GAAAC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47531489" stop="47531492" display_start="47531489" display_stop="47531492" variantLength="4" positionVCF="47531488" referenceAlleleVCF="GAAAC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N34fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.47531491_47531494del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.47531491_47531494del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.46111577_46111580del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.46111577_46111580del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008675.1" sequenceAccession="NG_008675" sequenceVersion="1" change="g.18459_18462del">
            <Expression>NG_008675.1:g.18459_18462del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001849.4" sequenceAccession="NM_001849" sequenceVersion="4" change="c.101_104del" MANESelect="true">
            <Expression>NM_001849.4:c.101_104del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001840.3" sequenceAccession="NP_001840" sequenceVersion="3" change="p.Asn34fs">
            <Expression>NP_001840.3:p.Asn34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058174.3" sequenceAccession="NM_058174" sequenceVersion="3" change="c.101_104del" MANEPlusClinical="true">
            <Expression>NM_058174.3:c.101_104del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478054.2" sequenceAccession="NP_478054" sequenceVersion="2" change="p.Asn34fs">
            <Expression>NP_478054.2:p.Asn34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058175.3" sequenceAccession="NM_058175" sequenceVersion="3" change="c.101_104del">
            <Expression>NM_058175.3:c.101_104del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478055.2" sequenceAccession="NP_478055" sequenceVersion="2" change="p.Asn34fs">
            <Expression>NP_478055.2:p.Asn34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_476" sequenceAccession="LRG_476">
            <Expression>LRG_476:g.18459_18462del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2123612919" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001849.4(COL6A2):c.101_104del (p.Asn34fs) AND multiple conditions" Accession="RCV002262189" Version="1">
        <ClassifiedConditionList TraitSetID="9730">
          <ClassifiedCondition DB="MedGen" ID="CN029274">Bethlem myopathy 1A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1850671">Myosclerosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0410179">Ullrich congenital muscular dystrophy 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-07-09" MostRecentSubmission="2022-07-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9730" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bethlem myopathy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bethlem myopathy 1A</ElementValue>
                <XRef ID="MONDO:0024530" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathy, benign congenital, with contractures</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1A</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="610" DB="Orphanet" />
              <XRef ID="CN029274" DB="MedGen" />
              <XRef ID="MONDO:0024530" DB="MONDO" />
              <XRef Type="MIM" ID="158810" DB="OMIM" />
            </Trait>
            <Trait ID="5602" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myosclerosis</ElementValue>
                <XRef ID="624040" DB="Illumina Laboratory Services, Illumina" />
                <XRef ID="MONDO:0009714" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, MYOSCLEROTIC</ElementValue>
                <XRef Type="MIM" ID="255600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOSCLEROSIS, CONGENITAL, OF LOWENTHAL</ElementValue>
                <XRef Type="MIM" ID="255600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myosclerosis, autosomal recessive</ElementValue>
                <XRef ID="Myosclerosis%2C+autosomal+recessive/8964" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myosclerosis, congenital</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17325" />
                <XRef ID="17325" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <XRef ID="289380" DB="Orphanet" />
              <XRef ID="C1850671" DB="MedGen" />
              <XRef ID="MONDO:0009714" DB="MONDO" />
              <XRef Type="MIM" ID="255600" DB="OMIM" />
            </Trait>
            <Trait ID="5081" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ullrich congenital muscular dystrophy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ullrich congenital muscular dystrophy 1A</ElementValue>
                <XRef ID="MONDO:0009681" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Late onset scleroatonic familial myopathy (subtype)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">UCMD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">UCMD1A</ElementValue>
                <XRef Type="MIM" ID="254090" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="75840" DB="Orphanet" />
              <XRef ID="C0410179" DB="MedGen" />
              <XRef ID="MONDO:0009681" DB="MONDO" />
              <XRef Type="MIM" ID="254090" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4978539" SubmissionDate="2022-07-08" DateLastUpdated="2022-07-09" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="22131|OMIM:255600;158810;254090" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002543819" DateUpdated="2022-07-09" DateCreated="2022-07-09" Type="SCV" Version="1" SubmitterName="Suma Genomics" OrgID="508066" OrganizationCategory="laboratory" OrgAbbreviation="Suma" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next Generation Sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL6A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001849.4:c.101_104del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="158810" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254090" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11768534</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4978539" TraitType="Disease" MappingType="XRef" MappingValue="255600" MappingRef="OMIM">
        <MedGen CUI="C1850671" Name="Myosclerosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4978539" TraitType="Disease" MappingType="XRef" MappingValue="158810" MappingRef="OMIM">
        <MedGen CUI="CN029274" Name="Bethlem myopathy 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4978539" TraitType="Disease" MappingType="XRef" MappingValue="254090" MappingRef="OMIM">
        <MedGen CUI="C0410179" Name="Ullrich congenital muscular dystrophy 1A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

